with cerebral malaria, a 36-year-old Chinese man was chosen as the subject of the investigation.
PATIENT AND METHODS

Patient and treatment
The patient, male, 36 years old, who had traveled to Africa for work, came back to China after a fourmonth stay in Nigeria. Approximately ten days after his return to China, he presented with signs and symptoms such as chills, fever, headache, dark urine and jaundice. Two hours following his admission to the hospital, the patient developed high fever and neck rigidity along with neuro-cognitive impairments.
Proper investigation was conducted and appropriate detection were ordered. The causative pathogen was identified as P. falciparum and a diagnosis of cerebral malaria was confirmed based on clinical presentation and laboratory results.
Artesunate was selected as the primary line of treatment and the patient was treated with 100 mg in three consecutive occasions; however, the patient's situation did not make progress and Artesunate was considered as becoming slowly effective by oral treatment and Artemether 80 mg was administered accordingly.
Consequently, the patient responded positively to the treatment and his conditions took a turn toward stability. In addition to Artemether, other medications such as mannitol and methylprednisolone were administrated to reduce intracranial pressure. Calculations of the plasmodium falciparum Peripheral blood smears were prepared and Giemsa's staining method was applied to determine the numbers of Plasmodium falciparum per 100 red blood cells.
Original Article
The number of pathogens per 100 red blood cells was calculated every day.
RESULTS
The patient with cerebrla malaria caused by P. falciparum was treated with Artemisinine, the relationship between the clearance of P. falciparum of quantitative results and the effects of the treatment was shown in Table 1 .
The patient was hospitalized for 10 days, and from the 7th day, Artemether intramuscular injection was suspended and changed to Artesunate orally. The patient was discharged on the 11th day, he walked out the hospital by foot and was told to keep taking Artesunate orally until back to hospital for the reexamination after 5 days. The condition of the patient in the 5th and 6th days was almost the same with that of the 7th day. From the 4th day, his peripheral blood plasmodium was undetectable ( Figure 1-Figure 3 ).
The quantity of the pathogen
The number of pathogens per 100 red blood cells was calculated for three consecutive days (16, 4, 2/100 RBC). On the 4th day the causative agent was no longer detectable Figure 4 .
DISCUSSION
Malaria is a mosquito-borne infectious disease caused by human malaria paracites. Commonly, the disease is transmitted via a bite from an infected female Anopheles mosquito, which transmits the organisms from its saliva into a person's circulation system. In the blood, the protists travel to the liver to mature and reproduce, then get into the RBC and proliferated more merozoites, which were finanlly released from the broken RBC and caused the clinical manifestation. The main representation of malaria is recurrent attacks of remittent chill, high fever and body temperature down to normal after profuse sweating. There are four kinds of plasmodium that can affect human being, Plasmodium vivax, Plasmodium ovale, malaria plasmodium and plasmodium falcparum. The pattern of fever in Falciparum malaria is irregular high fever, most cases were persistent fever without intermission. Cerebral malaria is the most severe type.
1,2
Most cerebral malaria cases were caused by Falciparum malaria, occasionally caused by plasmodium ovale. The main clinical manifestations are headache, fever and varying degree of conscious disturbance. The mechanism of onset of cerebral malaria was not very clear yet, present study believed that cerebral malaria onset was related to the cerebral capillary being blocked by infected RBC and the damage of the hemato encephalic barrier. The ligand produced by Plasmodium falci parum, for example PfEMP-1, 3 would help to attach on the RBC and became red blood cells infected by Plasmodium (PRBC), which adhered to each other, and also adhered to the vascular endothelial cell, causing PRBC stasis in the cerebral capillary and brain tissue hypoxia-ischemia. Plasmodium was a kind of antigen to the human body, which would stimulate to produce some soluble factors leading to the damage of the hemato encephalic barrier (BBB), 4 that would cause local BBB leaking, and some chemical substances such as saliva haemagglutinin was detectable in brain tissue. And the chemical substances or factors would cause the brain tissue damage and dysfunction. 5, 6 And in some severe cases with acute liver failure (ALF) would lead to hepatic encephalopathy(HE), which would contribute to the brain dysfunction as well. 7 Some other studies showed that in some severe cases with falciparum malarias, not even the brain tissue would be damage, but also other organs such as liver, kidney, ect, could be found capillary leak and bleeding, which could be one of the causes of multiple organ dysfunction. Moreover, some researches reported that some soluble media such as tumor necrosis factor, interleukin-1 would cause temporary neurotoxictiy and led to reversible conscious impairment. 5, 8, 9 Numerous broken RBC would cause severe acute anemia, led to brain tissue hypoxiaischemia, and worsen the conscious disturbance. 9 Regarding this case, after receiving effective pathogenic therapy (artesunate and artemether), the plasmodium decreased quickly. On the 1st day of admission (before the pathogenic treatment), the amount of P. falciparum was 16/100 RBC, which were 4/100 RBC and 2/100 RBC on the 2nd and 3rd day after pathogenic therapy, respectively. And from the 4th day, the plasmodium couldn't be found any more, which meaned that P. falciparum was sensitive to Artemisinin. Also, the clinical manifestation released, the body temperature dropped to normal gradually (dropping from the peak of 40.5℃ at the 1st day gradually to 36.7℃, and then back to normal completely). The neurological symptom of the patient progressed on the 1st day, with light coma, and consciousness became clearer day by day, then back to normal completely on the 7th day; and the meningeal irritation sign, neck rigidity released slowly, then the neck became flexible and could touch his sternum on the 7th day. The routine blood test showed the white blood cell (WBC), platelet and hemoglobin also improved as the clearance of P. falciparum. Our study showed that the severity to cerebral malaria was related to the amount of P. falciparum in peripheral blood. If the amount of P. falciparum was at a high level in the peripheral blood, the patient's manifestation was severe, and the manifestation released as the parasites decreased after treatment.
The manifestation of this case with cerebral falciparum malaria released quickly after treatment with Artemisinine, simutaneously with the plasmodium falci parum cleared in the blood stream, which implied that plasmodium falci parum might play a very important role directly in the mechanism of malaria.
